› Forums › General Melanoma Community › Some Good News on Adjuvant PD1
- This topic is empty.
- Post
-
- July 7, 2017 at 3:09 am
Hey folks thought I'd share some of this news that was brought up in the meeting with my onc yesterday.
I'm currently in a trial SWOG 1404 for resected stage 3b disease (micromets interestingly enough)-randomized to pembro.
Generally with every meeting I ask about the most up-to-date news/data on current trials and the 2017 ASCO
findings (thank you Bubbles for distiling all of that and sharing!).
Just a disclaimer: no specific stats have been released yet!
Here's the press release information that was brought to my attention on adjuvant Opdivo vs Yervoy trial-showing a "clear win for troubled PD-1 inhibitor in adjuvant melanoma therapy."
The data from this announcement will be released at a forthcoming conference (maybe a month or two from what I've heard).
All of this is very exciting info for us Stage 3bs/c'ers and even resected Stage 4 population with a high risk of relapse.
Here's the link:
http://www.pmlive.com/pharma_news/opdivo_tops_yervoy_in_adjuvant_melanoma_trial_1197714
What's more exciting are the eventual results of double combination Opdivo/Yervoy in the adjuvant setting. I'm sure we'll all be eager to see that data too.
- You must be logged in to reply to this topic.